Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria
- PMID: 35599722
- PMCID: PMC9110314
- DOI: 10.1016/j.jctube.2022.100319
Emerging threat of drug-resistant tuberculosis and trends in the era of COVID-19: A descriptive study from northwestern Nigeria
Abstract
Background: Mycobacterium tuberculosis with resistance to first line and second line anti tuberculous drugs is a serious setback in the treatment of tuberculosis (TB). The COVID-19 pandemic constitutes a serious threat that could unwind the recent gains made thus far in the control of tuberculosis. This study aims to explore the pattern of drug resistant tuberculosis (DRTB) in our institution. We also aimed to explore the changing trends of TB in the era of the COVID-19 pandemic.
Methods: This descriptive study included all DRTB patients admitted and managed in the hospital between January 2018 and December 2020. We compare TB case detection in the facility before and after COVID-19 pandemic. Drug susceptibility testing were expressed as frequencies and percentages.
Results: The study found that there was 66.03%, 45.09% and 77.78% drop in case detection of drug-sensitive TB (DSTB), DRTB and Fluoroquinolone (FQ) resistant TB respectively in the year 2020 compared to 2019. The drop in cases was similar when the year 2020 was compared to 2018. Among the 132 patients in the cohort, resistance to isoniazid, fluoroquinolones and second-line injectable agents were reported as 23.48%, 12.88%, and 31.06% respectively.
Conclusion: We question the potential reason why a drop in tuberculosis cases was observed in the year 2020 and we alert the Nigerian authorities that COVID-19 control efforts going hand-in-hand with intensified TB case finding and surveillance efforts and initiating proper TB treatment for persons with active TB are urgently needed.
Keywords: COVID-19; Drug-resistant TB; Nigeria; Tuberculosis.
© 2022 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Plasma levels of tumor necrosis factor-alpha, interferon-gamma, inducible nitric oxide synthase, and 3-nitrotyrosine in drug-resistant and drug-sensitive pulmonary tuberculosis patients, Ibadan, Nigeria.Int J Mycobacteriol. 2020 Apr-Jun;9(2):185-189. doi: 10.4103/ijmy.ijmy_63_20. Int J Mycobacteriol. 2020. PMID: 32474541
-
Pre-extensively drug-resistant tuberculosis among pulmonary multidrug-resistant tuberculosis patients in Eastern Nigeria.Lung India. 2023 Nov-Dec;40(6):492-495. doi: 10.4103/lungindia.lungindia_337_23. Lung India. 2023. PMID: 37961955 Free PMC article.
-
High prevalence of multi drug resistant tuberculosis in people living with HIV in Western India.BMC Infect Dis. 2019 May 8;19(1):391. doi: 10.1186/s12879-019-4042-z. BMC Infect Dis. 2019. PMID: 31068153 Free PMC article.
-
Genomic revolution: Transforming tuberculosis diagnosis and treatment with the use of Whole Genome Sequencing - A consensus statement.Indian J Tuberc. 2023 Oct;70(4):383-389. doi: 10.1016/j.ijtb.2023.10.002. Epub 2023 Oct 19. Indian J Tuberc. 2023. PMID: 37968042 Review.
-
Tuberculosis.In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
Cited by
-
Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone.Microbiol Spectr. 2024 Mar 5;12(3):e0240523. doi: 10.1128/spectrum.02405-23. Epub 2024 Jan 30. Microbiol Spectr. 2024. PMID: 38289066 Free PMC article.
-
Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control.Front Public Health. 2024 May 16;12:1374703. doi: 10.3389/fpubh.2024.1374703. eCollection 2024. Front Public Health. 2024. PMID: 38827613 Free PMC article. Review.
-
Trends in Rifampicin Resistance Among Children With Presumptive TB in the Pre-COVID and COVID-Era.Glob Pediatr Health. 2023 Feb 17;10:2333794X231156048. doi: 10.1177/2333794X231156048. eCollection 2023. Glob Pediatr Health. 2023. PMID: 36814532 Free PMC article.
-
Drug-Resistant Tuberculosis Hotspots in Oliver Reginald Tambo District Municipality, Eastern Cape, South Africa.Infect Dis Rep. 2024 Dec 6;16(6):1197-1213. doi: 10.3390/idr16060095. Infect Dis Rep. 2024. PMID: 39728017 Free PMC article.
-
Drug-resistant tuberculosis care and treatment outcomes over the last 15 years in Ethiopia: Results from a mixed-method review of trends.PLoS One. 2024 Aug 26;19(8):e0306076. doi: 10.1371/journal.pone.0306076. eCollection 2024. PLoS One. 2024. PMID: 39186714 Free PMC article.
References
-
- G. Sotgiu, G. Sulis, and A. Matteelli Tuberculosis—A world health organization perspective Tuberculosis and Nontuberculous Mycobacterial Infections, (2017), pp. 211-228.
-
- Federal Republic of Nigeria Report: First National TB Prevalence Survey, 2012, Nigeria 2012.
-
- WHO, Global tuberculosis report 2020: executive summary, 2020.
Grants and funding
LinkOut - more resources
Full Text Sources